ArticleCancer gene therapy2026

Exploration of the mechanism of anlotinib in reversing PD-1 immunotherapy resistance: insights from single-cell sequencing.

Wanjin Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.